european medicines agency glp-1 vision loss recommendation november 2025 What is the pipeline for future medications for obesity? ema glp-1 vision loss recommendation

A comprehensive approach to lasting results consistent weight loss without yo-yo dieting and a healthier rhythm in daily life

This distinction matters because allergic itching would warrant immediate discontinuation, whereas GLP-1-related itching often resolves with continued use or temporary dose adjustment

Lifestyle factors that complement both treatments Regardless of whether someone is on Toujeo, a GLP-1 medication, or both, lifestyle factors play a critical role in treatment success

For daily formulations, consistent timing is important

15 The prohibition against producing drugs that are essentially copies of approved products protects the integrity and effectiveness of the new drug and abbreviated new drug approval processes